CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma
CD79B Y196 突变是原发性中枢神经系统淋巴瘤对 R-MPV 治疗反应良好的强效预测标志物
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5512
Yamaguchi, Junya; Ohka, Fumiharu; Lushun, Chalise; Motomura, Kazuya; Aoki, Kosuke; Takeuchi, Kazuhito; Nagata, Yuichi; Ito, Satoshi; Mizutani, Nobuhiko; Ohno, Masasuke; Suzaki, Noriyuki; Takasu, Syuntaro; Seki, Yukio; Kano, Takahisa; Wakabayashi, Kenichi; Oyama, Hirofumi; Kurahashi, Shingo; Tanahashi, Kuniaki; Hirano, Masaki; Shimizu, Hiroyuki; Kitano, Yotaro; Maeda, Sachi; Yamazaki, Shintaro; Wakabayashi, Toshihiko; Kondo, Yutaka; Natsume, Atsushi; Saito, Ryuta